MENU
ALNY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Alnylam Pharmaceuticals (ALNY) Earnings Date & Reports

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

ALNY is expected to report earnings to fall 1,644.33% to -92 cents per share on May 01

Alnylam Pharmaceuticals ALNY Stock Earnings Reports
Q1'25
Est.
$-0.93
Q4'24
Beat
by $0.64
Q3'24
Beat
by $0.43
Q2'24
Beat
by $1.61
Q1'24
Beat
by $0.98
The last earnings report on February 13 showed earnings per share of 5 cents, beating the estimate of -57 cents. With 137.07K shares outstanding, the current market capitalization sits at 34.53B.
View a ticker or compare two or three
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapeutics based on RNA interference

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
675 West Kendall Street
Phone
+1 617 551-8200
Employees
2100
Web
https://www.alnylam.com